CA2570474C - A combination composition comprising paracetamol and ibuprofen - Google Patents
A combination composition comprising paracetamol and ibuprofen Download PDFInfo
- Publication number
- CA2570474C CA2570474C CA002570474A CA2570474A CA2570474C CA 2570474 C CA2570474 C CA 2570474C CA 002570474 A CA002570474 A CA 002570474A CA 2570474 A CA2570474 A CA 2570474A CA 2570474 C CA2570474 C CA 2570474C
- Authority
- CA
- Canada
- Prior art keywords
- ibuprofen
- paracetamol
- composition according
- composition
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Emergency Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Rheumatology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NZ53398204 | 2004-07-07 | ||
| NZ533982 | 2004-07-07 | ||
| PCT/NZ2005/000168 WO2006004449A2 (en) | 2004-07-07 | 2005-07-07 | A combination composition |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2570474A1 CA2570474A1 (en) | 2006-01-12 |
| CA2570474C true CA2570474C (en) | 2010-01-05 |
Family
ID=35783254
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002570474A Expired - Lifetime CA2570474C (en) | 2004-07-07 | 2005-07-07 | A combination composition comprising paracetamol and ibuprofen |
Country Status (21)
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0512756A (pt) | 2004-07-07 | 2008-04-08 | Aft Pharmaceuticals Ltd | composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas |
| ZA200803566B (en) * | 2005-12-12 | 2009-10-28 | Adcock Ingram Ltd | Pharmaceutical compositions |
| ES2651444T3 (es) * | 2006-10-20 | 2018-01-26 | Johnson & Johnson Consumer Inc. | Combinación de acetaminofeno con ibuprofeno para el tratamiento del dolor |
| JP5676834B2 (ja) * | 2006-11-29 | 2015-02-25 | エスエス製薬株式会社 | 消化管への刺激性を減少した経口固形組成物 |
| CA2731801C (en) * | 2007-07-23 | 2013-11-26 | Kingsway Pharmaceuticals Inc. | Therapeutic formulations for the treatment of cold and flu-like symptoms |
| KR20110065417A (ko) * | 2008-01-03 | 2011-06-15 | 욱크하르트 리미티드 | 파라세타몰 및 이부프로펜을 포함하는 경구 약제학적 현탁액 |
| TR201906742T4 (tr) | 2008-10-14 | 2019-05-21 | Aft Pharmaceuticals Ltd | Tıbbi bir ürün ve tedavi. |
| DE102010008876B4 (de) | 2010-02-22 | 2017-07-27 | Integrated Micro-Electronics Bulgaria | Lichtquelle mit Array-LEDs zum direkten Betrieb am Wechselspannungsnetz und Herstellungsverfahren hierfür |
| NZ604009A (en) * | 2010-07-07 | 2015-03-27 | Aft Pharmaceuticals Ltd | A combination composition comprising ibuprofen and paracetamol |
| ES2742373T3 (es) * | 2010-11-04 | 2020-02-14 | Aft Pharmaceuticals Ltd | Una composición de combinación |
| BR112013028668A2 (pt) * | 2011-05-06 | 2017-01-24 | Glaxosmithkline Llc | formulações de paracetamol de liberação sustentada |
| JP6009928B2 (ja) * | 2012-12-14 | 2016-10-19 | ダイハツ工業株式会社 | 車両のサスペンション |
| KR102373089B1 (ko) * | 2017-03-30 | 2022-03-11 | 한미약품 주식회사 | 이부프로펜 및 아세트아미노펜을 포함하는 약제학적 조성물 및 이의 제조방법 |
| EP4480495A3 (en) * | 2017-07-10 | 2025-06-18 | Gel Cap Technologies, LLC | Dual release dosage form capsule and methods, devices and systems for making same |
| WO2019108147A1 (en) | 2017-11-29 | 2019-06-06 | İlko İlaç Sanayi̇ Ve Ti̇caret A.Ş. | Color stable fixed dose tablet combination of ibuprofen and paracetamol |
| US11197830B2 (en) | 2019-02-27 | 2021-12-14 | Aft Pharmaceuticals Limited | Pharmaceutical composition containing acetaminophen and ibuprofen |
| PH12021553169A1 (en) | 2019-06-27 | 2022-08-15 | Glaxosmithkline Consumer Healthcare Holdings Us Llc | Novel ibuprofen and acetaminophen composition |
| WO2023281089A2 (en) | 2021-07-08 | 2023-01-12 | Krka, D.D., Novo Mesto | Pharmaceutical composition comprising naproxen and paracetamol |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU605538B2 (en) * | 1988-01-19 | 1991-01-17 | Adcock Ingram Limited | Pharmaceutical unit |
| CA1336687C (en) * | 1989-08-23 | 1995-08-15 | Thomas M. Tencza | Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products |
| JP3122748B2 (ja) * | 1991-11-29 | 2001-01-09 | ライオン株式会社 | イブプロフェン含有解熱鎮痛剤 |
| US5409709A (en) * | 1991-11-29 | 1995-04-25 | Lion Corporation | Antipyretic analgesic preparation containing ibuprofen |
| US5260337A (en) * | 1992-07-29 | 1993-11-09 | Merck & Co., Inc. | Ibuprofen-muscle relaxant combinations |
| ZA959469B (en) | 1994-11-15 | 1996-05-15 | South African Druggists Ltd | Pharmaceutical composition |
| KR970000231A (ko) * | 1995-06-12 | 1997-01-21 | 박형미 | 진통소염제의 의약조성물 |
| JP3982889B2 (ja) | 1997-11-28 | 2007-09-26 | あすか製薬株式会社 | イブプロフェン含有医薬製剤 |
| US6440983B1 (en) * | 2000-12-21 | 2002-08-27 | Mary Theresa Frank-Kollman | Compositions and methods for relieving headache symptoms in aspirin-sensitive headache sufferers |
| BRPI0512756A (pt) | 2004-07-07 | 2008-04-08 | Aft Pharmaceuticals Ltd | composição farmacêutica de combinação para o tratamento de dor, método de controle de dor, uso de uma composição e embalagem farmacêutica incluindo comprimidos ou cápsulas |
| GB0519350D0 (en) | 2005-09-22 | 2005-11-02 | Boots Healthcare Int Ltd | Therapeutic agents |
| US20090264530A1 (en) | 2008-04-16 | 2009-10-22 | Nickell Robert P | Combined nsaid and acetaminophen formulation and method |
| TR201906742T4 (tr) | 2008-10-14 | 2019-05-21 | Aft Pharmaceuticals Ltd | Tıbbi bir ürün ve tedavi. |
-
2005
- 2005-07-07 BR BRPI0512756-4A patent/BRPI0512756A/pt not_active Application Discontinuation
- 2005-07-07 CN CNA2005800222148A patent/CN101022789A/zh active Pending
- 2005-07-07 PL PL05764510T patent/PL1781277T3/pl unknown
- 2005-07-07 CA CA002570474A patent/CA2570474C/en not_active Expired - Lifetime
- 2005-07-07 WO PCT/NZ2005/000168 patent/WO2006004449A2/en not_active Ceased
- 2005-07-07 US US11/570,887 patent/US20080275125A1/en not_active Abandoned
- 2005-07-07 EP EP05764510A patent/EP1781277B1/en not_active Expired - Lifetime
- 2005-07-07 PT PT05764510T patent/PT1781277E/pt unknown
- 2005-07-07 GB GB0700027A patent/GB2431346C/en not_active Expired - Lifetime
- 2005-07-07 MX MX2007000117A patent/MX2007000117A/es active IP Right Grant
- 2005-07-07 AU AU2005260243A patent/AU2005260243B2/en active Active
- 2005-07-07 JP JP2007520251A patent/JP5630943B2/ja not_active Expired - Fee Related
- 2005-07-07 AT AT05764510T patent/ATE543491T1/de active
- 2005-07-07 DK DK05764510.3T patent/DK1781277T3/da active
- 2005-07-07 ES ES05764510T patent/ES2381794T3/es not_active Expired - Lifetime
- 2005-07-07 RU RU2007101686/15A patent/RU2007101686A/ru unknown
- 2005-07-07 KR KR1020077002407A patent/KR101370712B1/ko not_active Expired - Lifetime
- 2005-07-07 SI SI200531517T patent/SI1781277T1/sl unknown
-
2007
- 2007-01-31 ZA ZA200700896A patent/ZA200700896B/en unknown
-
2008
- 2008-04-30 US US12/113,171 patent/US20080200549A1/en not_active Abandoned
- 2008-05-07 AU AU2008202029A patent/AU2008202029A1/en not_active Abandoned
-
2010
- 2010-09-30 US US12/924,812 patent/US20110275718A1/en not_active Abandoned
- 2010-11-19 RU RU2010147287/15A patent/RU2455983C1/ru active IP Right Revival
-
2012
- 2012-04-30 CY CY20121100406T patent/CY1112738T1/el unknown
-
2013
- 2013-04-05 US US13/857,802 patent/US10532036B2/en not_active Expired - Lifetime
-
2023
- 2023-12-19 CY CY2023026C patent/CY2023026I2/el unknown
-
2024
- 2024-01-23 LT LTPA2024501C patent/LTC1781277I2/lt unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10532036B2 (en) | Combination composition | |
| AU603675B2 (en) | Pharmaceutical sustained release matrix and process | |
| US5004613A (en) | Oral sustained release pharmaceutical formulation and process | |
| CA2740146A1 (en) | Immediate release dosage forms of sodium oxybate | |
| NL8302842A (nl) | Naproxeen en naproxeen natrium tabletten met een geregelde afgifte. | |
| AU2001260212A1 (en) | Composition | |
| EP1274402A1 (en) | Pharmaceutical composition for the controlled release of paracetamol | |
| US20250302754A1 (en) | Novel ibuprofen and acetaminophen composition | |
| MXPA04009906A (es) | Composiciones farmaceuticas de liberacion controlada de carbipoda y levopoda. | |
| US10098856B2 (en) | Alternating sympathomimetic therapy for the treatment of respiratory ailments | |
| NZ552181A (en) | Combination of acetaminophen and ibuprofen | |
| WO2013115737A2 (en) | New pharmaceutical compositions of flurbiprofen and glucosamin | |
| EP2948133B1 (en) | Pharmaceutical combinations of flurbiprofen, glucosamin and capsaicin | |
| HK1053601B (en) | Pharmaceutical composition for the controlled release of paracetamol |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |